GSK Insider Trading

Insider Ownership Percentage: 1.61%
Insider Buying (Last 12 Months): £437,124.90
Insider Selling (Last 12 Months): £2,317,751.36

GSK Insider Trading History Chart

This chart shows the insider buying and selling history at GSK by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

GSK Share Price & Price History

Current Price: GBX 1,348.75
Price Change: Price Decrease of -24.75 (-1.80%)
As of 12/11/2024 01:36 PM ET

This chart shows the closing price history over time for GSK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

GSK Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/11/2024Julie BrownInsiderBuy8GBX 1,399£111.92
10/30/2024Jonathan SymondsInsiderBuy7,150GBX 1,394£99,671
9/23/2024Elizabeth (Liz) McKee AndersonInsiderBuy446GBX 2,051£9,147.46
8/9/2024Julie BrownInsiderBuy8GBX 1,505£120.40
6/20/2024Wendy BeckerInsiderBuy446GBX 1,614£7,198.44
6/11/2024Julie BrownInsiderBuy8GBX 1,623£129.84
3/20/2024Urs RohnerInsiderBuy434GBX 1,662£7,213.08
2/16/2024Emma WalmsleyInsiderSell139,792GBX 1,658£2,317,751.36
2/9/2024Emma WalmsleyInsiderBuy8GBX 1,662£132.96
2/1/2024Julie BrownInsiderBuy19,360GBX 1,583£306,468.80
12/20/2023Urs RohnerInsiderBuy478GBX 1,450£6,931
9/20/2023Hal BarronInsiderBuy219GBX 3,803£8,328.57
8/24/2023Hal BarronInsiderSell19,446GBX 3,462£673,220.52
8/9/2023Emma WalmsleyInsiderBuy9GBX 1,376£123.84
7/11/2023Emma WalmsleyInsiderBuy9GBX 1,307£117.63
6/23/2023Jonathan SymondsInsiderBuy6,000GBX 1,440£86,400
6/9/2023Emma WalmsleyInsiderBuy9GBX 1,380£124.20
5/11/2023Emma WalmsleyInsiderBuy9GBX 1,454£130.86
4/18/2023Iain MackayInsiderBuy200GBX 1,493£2,986
3/20/2023Jonathan SymondsInsiderBuy2,100GBX 1,399£29,379
2/14/2023Emma WalmsleyInsiderSell28,576GBX 1,487£424,925.12
2/9/2023Emma WalmsleyInsiderBuy8GBX 1,514£121.12
1/11/2023Emma WalmsleyInsiderBuy9GBX 1,417£127.53
12/22/2022Urs RohnerInsiderBuy798GBX 1,453£11,594.94
12/20/2022Jonathan SymondsInsiderBuy2,100GBX 1,417£29,757
11/9/2022Emma WalmsleyInsiderBuy8GBX 1,396£111.68
9/29/2022Jonathan SymondsInsiderBuy3,220GBX 1,324£42,632.80
9/9/2022Emma WalmsleyInsiderBuy9GBX 1,362£122.58
8/9/2022Emma WalmsleyInsiderBuy8GBX 1,641£131.28
7/27/2022Emma WalmsleyInsiderSell148,525GBX 1,763£2,618,495.75
7/4/2022Emma WalmsleyInsiderBuy7GBX 1,799£125.93
6/23/2022Manvinder Singh BangaInsiderBuy647GBX 1,691£10,940.77
3/23/2022Charles BancroftInsiderBuy2,790GBX 2,114£58,980.60
2/14/2022Emma WalmsleyInsiderSell34,031GBX 1,610£547,899.10
2/9/2022Emma WalmsleyInsiderBuy8GBX 1,627£130.16
1/12/2022Emma WalmsleyInsiderBuy7GBX 1,638£114.66
See Full Table

SEC Filings (Institutional Ownership Changes) for GSK (LON:GSK)

45.33% of GSK stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

GSK logo
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Read More on GSK

Today's Range

Now: GBX 1,348.75
Low: 1,340
High: 1,368

50 Day Range

MA: GBX 1,414.54
Low: 1,300
High: 1,537

52 Week Range

Now: GBX 1,348.75
Low: 1,282.50
High: 1,823.50

Volume

15,119,753 shs

Average Volume

10,042,368 shs

Market Capitalization

£55.03 billion

P/E Ratio

1,193.58

Dividend Yield

3.99%

Beta

0.31

Who are the company insiders with the largest holdings of GSK?

GSK's top insider shareholders include:
  1. Elizabeth (Liz) McKee Anderson (Insider)
  2. Emma Walmsley (Insider)
  3. Hal Barron (Insider)
  4. Iain Mackay (Insider)
  5. Jonathan Symonds (Insider)
  6. Julie Brown (Insider)
  7. Urs Rohner (Insider)
  8. Wendy Becker (Insider)
Learn More about top insider investors at GSK.